Alerts for Hypertension: Not a Substitute for Screening

The convenience of health tracking on smartwatches is growing, but a recent analysis underscores a critical point: an alert from your Apple Watch suggesting possible hypertension shouldn’t be considered a substitute for traditional blood pressure screening. While the technology can raise awareness and potentially prompt individuals to seek medical attention, relying solely on these alerts carries the risk of both false reassurance and unnecessary anxiety.

How Apple Watch Hypertension Notifications Work

In September 2025, the U.S. Food and Drug Administration cleared Apple’s Hypertension Notifications Feature, a tool that uses the watch’s optical sensors to detect patterns in blood flow. The feature isn’t designed to diagnose high blood pressure, but rather to alert users when data suggest a potential issue. It operates by analyzing data over a 30-day period, looking for consistent patterns indicative of elevated blood pressure. Apple explicitly states the feature is not intended to diagnose, treat, or manage hypertension, and acknowledges that not everyone with high blood pressure will receive a notification, nor can the watch detect heart attacks. More details on the feature’s limitations are available from Yahoo Health.

The Recent Study: Real-World Impact and Limitations

Researchers from the University of Utah and the University of Pennsylvania recently published an analysis in the Journal of the American Medical Association examining the potential impact of widespread use of these smartwatch alerts. The study built upon prior analysis conducted by Apple itself, which had already identified rates of false positives and false negatives associated with the Hypertension Notifications Feature. The new research sought to estimate how these rates would translate in the broader U.S. Adult population.

The findings reveal a nuanced picture. According to Apple’s reported test performance, approximately 41.2% of individuals with undiagnosed hypertension would receive an alert, while 58.8% would not. Conversely, among those without hypertension, 92.3% would not receive an alert, but 7.7% would receive an inappropriate alert – a false positive. This suggests the alerts offer “moderate evidence to rule in hypertension” but only “weak evidence to rule out hypertension.” In other words, an alert is a reason to investigate further, but the absence of an alert doesn’t guarantee normal blood pressure.

Adam Bress, Pharm.D., M.S., a researcher at the University of Utah, emphasized the significance of this finding, noting that high blood pressure is often called a “silent killer” because it frequently presents no noticeable symptoms. The University of Utah Health newsroom provides further context on the study’s findings.

What Does This Signify for Individuals?

The study doesn’t suggest smartwatches are useless in monitoring cardiovascular health. Rather, it highlights the importance of interpreting the data they provide with caution and in consultation with a healthcare professional. An alert should be viewed as a prompt to schedule a traditional blood pressure check with a cuff-based measurement, not as a definitive diagnosis.

The risk of “false reassurance” is particularly concerning. Individuals who don’t receive an alert might mistakenly believe their blood pressure is normal, potentially delaying necessary medical attention. This is especially relevant given that high blood pressure is a leading modifiable cause of heart disease.

The Importance of Traditional Screening

Current guidelines from organizations like the U.S. Preventive Services Task Force (USPSTF) recommend regular blood pressure screening for adults 18 years and older. The USPSTF recommends obtaining blood pressure measurements both in a clinical setting and outside of it for diagnostic confirmation. The USPSTF’s recommendation statement is available on the JAMA Network. These screenings typically involve using a cuff-based device to measure blood pressure accurately and reliably.

The accuracy of cuff-based measurements is well-established, and they remain the gold standard for diagnosing hypertension. While smartwatch technology offers a convenient and potentially valuable tool for monitoring health trends, it’s not yet sophisticated enough to replace this established method.

Demographic Considerations and Alert Accuracy

The likelihood that an alert accurately reflects true hypertension appears to vary depending on age. The study did not detail specific age-related variations in alert accuracy, but it did note that user demographics play a role. This suggests that the technology may be more reliable for certain populations than others, and further research is needed to understand these differences.

What Comes Next: Ongoing Research and Guidance Updates

The findings from this study are likely to inform ongoing discussions about the role of wearable technology in healthcare. Researchers will continue to evaluate the performance of these devices and refine their algorithms to improve accuracy. It’s as well possible that public health guidelines will be updated to reflect the evolving capabilities of these technologies. For now, the message is clear: smartwatches can be a helpful tool, but they are not a replacement for regular, cuff-based blood pressure screening. Individuals should continue to prioritize these screenings and discuss any concerns about their blood pressure with a qualified clinician.